Forging a position as an innovative player in
infectious disease vaccines and therapies

Home
About
Our Technology
Business Development
- Partner Network
- Licensing Strategy and Available Licenses
Investor Relations
Contact Us
- Corporate directory

BioDiem » » Chinese FDA gives approval to start LAIV vaccine clinical trials

Chinese FDA gives approval to start LAIV vaccine clinical trials September 24, 2015 • Category • Author Name

Chinese FDA gives approval to start LAIV vaccine clinical trials

Latest News

BioDiem Shareholder Update

October 29, 2025

BioDiem Shareholder Update

Read More
BioDiem Update and EOFY 25 Information

August 6, 2025

BioDiem Update and EOFY 25 Information

Read More

Join our email list!

Join our email distribution list to be updated with announcements.

© Copyright 2014 BioDiem

Privacy Policy
Terms and conditions